首页 › 肺癌 › 艾奥瓦州 › Cedar Rapids
Cedar Rapids IA 肺癌临床试验
14项针对 肺癌的研究正在 Cedar Rapids及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
招募中3 期
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
招募中3 期
- University of Iowa Hospitals & Clinics, Iowa City · 距离 25 英里
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
招募中1/2 期
- Local Institution - 0065, Iowa City · 距离 25 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · 距离 25 英里
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
招募中3 期
- University of Iowa, Iowa City · 距离 25 英里
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- Helen G. Nassif Community Cancer Center, Cedar Rapids
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
招募中3 期
- Saint Luke's Hospital, Cedar Rapids
CHAMP Lung Cancer Screening Program
招募中
- University of Iowa, Iowa City · 距离 25 英里
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
招募中1/2 期
- University of Iowa Health Care, Iowa City · 距离 25 英里
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
招募中2 期
- University of Iowa Hospitals and Clinics, Iowa City · 距离 25 英里
Using Xe MRI to Guide Radiation Therapy for Lung Cancer
招募中2 期
- University of Iowa, Iowa City · 距离 25 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Iowa City · 距离 25 英里
其他城市的 肺癌试验
- Houston, TX78 项研究
- Boston, MA62 项研究
- New York City, NY60 项研究
- Los Angeles, CA45 项研究
- Arlington, VA41 项研究
- Washington, DC41 项研究
- Chicago, IL41 项研究
- Baltimore, MD40 项研究
- Nashville, TN40 项研究
- St. Louis, MO39 项研究
- Columbus, OH37 项研究
- Philadelphia, PA36 项研究
Cedar Rapids的其他研究
- 非小细胞肺癌20 项研究
- 乳腺癌17 项研究
- 癌症（所有类型）16 项研究
- 急性髓系白血病16 项研究
- 多发性骨髓瘤15 项研究
- 结直肠癌13 项研究
- 头颈鳞状细胞癌12 项研究
- 前列腺癌12 项研究
- 卒中10 项研究
- 黑色素瘤10 项研究
- 子宫内膜癌9 项研究
- 血液癌症9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。